Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

BACKGROUND: The current mainstay of therapy for chronic obstructive pulmonary disease (COPD) is long-acting bronchodilators. To date, the effect of indacaterol, a β2-agonist, on activities of daily living in COPD patients is not well understood. The aim of this study was to evaluate the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hataji, Osamu, Naito, Masahiro, Ito, Kentaro, Watanabe, Fumiaki, Gabazza, Esteban C, Taguchi, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534442/
https://www.ncbi.nlm.nih.gov/pubmed/23293514
http://dx.doi.org/10.2147/COPD.S38548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534442/
https://www.ncbi.nlm.nih.gov/pubmed/23293514
http://dx.doi.org/10.2147/COPD.S38548

Ejemplares similares